{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:37:02Z","timestamp":1792175822777,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Claude D. Pepper Older Americans Independence Centers","award":["P30 AG021332"],"award-info":[{"award-number":["P30 AG021332"]}]},{"DOI":"10.13039\/100008635","name":"UTHSCSA","doi-asserted-by":"publisher","award":["P30 AG044271"],"award-info":[{"award-number":["P30 AG044271"]}],"id":[{"id":"10.13039\/100008635","id-type":"DOI","asserted-by":"publisher"}]},{"name":"San Antonio Nathan Shock Center","award":["P30 AG013319"],"award-info":[{"award-number":["P30 AG013319"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K01 AG059837"],"award-info":[{"award-number":["K01 AG059837"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R37 AG13925"],"award-info":[{"award-number":["R37 AG13925"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R15 AG059190"],"award-info":[{"award-number":["R15 AG059190"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R03 AG059846"],"award-info":[{"award-number":["R03 AG059846"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Connor Group"},{"name":"Glenn Foundations"},{"name":"CTSA","award":["3UL1TR002645"],"award-info":[{"award-number":["3UL1TR002645"]}]}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ebiom.2018.12.052","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T21:24:10Z","timestamp":1546637050000},"page":"554-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1229,"special_numbering":"C","title":["Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study"],"prefix":"10.1016","volume":"40","author":[{"given":"Jamie N.","family":"Justice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop M.","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Tchkonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan K.","family":"LeBrasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrukh K.","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Prata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8483-930X","authenticated-orcid":false,"given":"Michal M.","family":"Masternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Kritchevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Musi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kirkland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9807","key":"10.1016\/j.ebiom.2018.12.052_bb0005","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/CLEP.S54815","article-title":"Epidemiology of idiopathic pulmonary fibrosis","volume":"5","author":"Ley","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.052_bb0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ebiom.2018.12.052_bb0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S2213-2600(14)70101-8","article-title":"Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11","volume":"2","author":"Raghu","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0025","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.052_bb0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1164\/rccm.201202-0282PP","article-title":"Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis","volume":"186","author":"Faner","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.ebiom.2018.12.052_bb0035","doi-asserted-by":"crossref","first-page":"e87732","DOI":"10.1172\/jci.insight.87732","article-title":"Elimination of p19(ARF)-expressing cells enhances pulmonary function in mice","volume":"1","author":"Hashimoto","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","article-title":"Cellular senescence: a translational perspective","volume":"21","author":"Kirkland","year":"2017","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.052_bb0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MCO.0000000000000065","article-title":"Cellular senescence and the senescent secretory phenotype in age-related chronic diseases","volume":"17","author":"Zhu","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.052_bb0050","first-page":"58","article-title":"Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers","volume":"5","author":"Lomas","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.052_bb0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles' heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exger.2014.10.012","article-title":"Clinical strategies and animal models for developing senolytic agents","volume":"68","author":"Kirkland","year":"2015","journal-title":"Exp Gerontol"},{"issue":"9","key":"10.1016\/j.ebiom.2018.12.052_bb0065","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1172\/JCI22475","article-title":"Ink4a\/Arf expression is a biomarker of aging","volume":"114","author":"Krishnamurthy","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Coppe","year":"2010","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"10.1016\/j.ebiom.2018.12.052_bb0075","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Coppe","year":"2008","journal-title":"PLoS Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2018.12.052_bb0080","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","article-title":"Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network","volume":"133","author":"Kuilman","year":"2008","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ebiom.2018.12.052_bb0085","first-page":"2284","article-title":"Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved","volume":"55","author":"Wang","year":"1995","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.ebiom.2018.12.052_bb0090","doi-asserted-by":"crossref","first-page":"955","DOI":"10.18632\/aging.101202","article-title":"New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463","volume":"9","author":"Zhu","year":"2017","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.052_bb0095","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41467-017-00314-z","article-title":"Identification of HSP90 inhibitors as a novel class of senolytics","volume":"8","author":"Fuhrmann-Stroissnigg","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.ebiom.2018.12.052_bb0100","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nm.4385","article-title":"Targeting cellular senescence prevents age-related bone loss in mice","volume":"23","author":"Farr","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15691","article-title":"Cellular senescence drives age-dependent hepatic steatosis","volume":"8","author":"Ogrodnik","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2018.12.052_bb0110","doi-asserted-by":"crossref","first-page":"e12840","DOI":"10.1111\/acel.12840","article-title":"Tau protein aggregation is associated with cellular senescence in the brain","volume":"17","author":"Musi","year":"2018","journal-title":"Aging Cell"},{"issue":"13","key":"10.1016\/j.ebiom.2018.12.052_bb0115","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.2018.12440","article-title":"Aging, cell senescence, and chronic disease: emerging therapeutic strategies","volume":"320","author":"Tchkonia","year":"2018","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ebiom.2018.12.052_bb0120","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","article-title":"Senolytics improve physical function and increase lifespan in old age","volume":"24","author":"Xu","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2018.12.052_bb0125","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/acel.12458","article-title":"Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice","volume":"15","author":"Roos","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","article-title":"Fisetin is a senotherapeutic that extends health and lifespan","volume":"36","author":"Yousefzadeh","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0135","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3389\/fimmu.2018.01056","article-title":"Frailty in older adults is associated with plasma concentrations of inflammatory mediators but not with lymphocyte subpopulations","volume":"9","author":"Marcos-Perez","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.052_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12706","article-title":"Circulating levels of monocyte chemoattractant protein-1 as a potential measure of biological age in mice and frailty in humans","volume":"17","author":"Yousefzadeh","year":"2018","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2018.12.052_bb0145","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12209","article-title":"Circulating activin A predicts survival in cancer patients","volume":"8","author":"Loumaye","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.ebiom.2018.12.052_bb0150","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41591-018-0131-6","article-title":"The exerkine apelin reverses age-associated sarcopenia","volume":"24","author":"Vinel","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.052_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050093","article-title":"MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"5","author":"Rosas","year":"2008","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.ebiom.2018.12.052_bb0160","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.201505-0862OC","article-title":"Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias","volume":"194","author":"White","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"34","key":"10.1016\/j.ebiom.2018.12.052_bb0165","doi-asserted-by":"crossref","first-page":"35509","DOI":"10.18632\/oncotarget.5899","article-title":"DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging","volume":"6","author":"Olivieri","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.052_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1165\/rcmb.2016-0163OC","article-title":"miR-34a inhibits lung fibrosis by inducing lung fibroblast senescence","volume":"56","author":"Cui","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.052_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169213","article-title":"Changes of ovarian microRNA profile in long-living ames dwarf mice during aging","volume":"12","author":"Schneider","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.052_bb0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.18632\/aging.100042","article-title":"MicroRNAs miR-146a\/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8","volume":"1","author":"Bhaumik","year":"2009","journal-title":"Aging (Albany NY)."},{"issue":"11","key":"10.1016\/j.ebiom.2018.12.052_bb0185","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.18632\/oncotarget.7858","article-title":"Anti-TNF-alpha treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells","volume":"7","author":"Prattichizzo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mad.2014.11.001","article-title":"Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy--a study with monozygotic twin pairs","volume":"143-144","author":"Kangas","year":"2014","journal-title":"Mech Ageing Dev"},{"issue":"15","key":"10.1016\/j.ebiom.2018.12.052_bb0195","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.2015.10962","article-title":"Pilot studies: a critical but potentially misused component of interventional research","volume":"314","author":"Kistin","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ebiom.2018.12.052_bb0200","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jpsychires.2010.10.008","article-title":"The role and interpretation of pilot studies in clinical research","volume":"45","author":"Leon","year":"2011","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.ebiom.2018.12.052_bb0205","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/0962280215588241","article-title":"Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable","volume":"25","author":"Whitehead","year":"2016","journal-title":"Stat Methods Med Res"},{"issue":"10","key":"10.1016\/j.ebiom.2018.12.052_bb0210","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1111\/jgs.14969","article-title":"The Clinical potential of Senolytic Drugs","volume":"65","author":"Kirkland","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"10.1016\/j.ebiom.2018.12.052_bb0215","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/dmd.107.018267","article-title":"Metabolism and disposition of dasatinib after oral administration to humans","volume":"36","author":"Christopher","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.052_bb0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/bdd.605","article-title":"Quercetin pharmacokinetics in humans","volume":"29","author":"Moon","year":"2008","journal-title":"Biopharm Drug Dispos"},{"issue":"22","key":"10.1016\/j.ebiom.2018.12.052_bb0225","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ebiom.2018.12.052_bb0230","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ebiom.2018.12.052_bb0235","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jamda.2015.03.027","article-title":"A frailty index based on common laboratory tests in comparison with a clinical frailty index for older adults in long-term care facilities","volume":"16","author":"Rockwood","year":"2015","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.052_bb0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"Laboratories ATSCoPSfCPF","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ebiom.2018.12.052_bb0245","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1164\/rccm.19310erratum","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"193","author":"Erratum","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.052_bb0250","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"key":"10.1016\/j.ebiom.2018.12.052_bb0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fonc.2018.00217","article-title":"Blood serum from head and neck squamous cell carcinoma patients induces altered microrna and target gene expression profile in treated cells","volume":"8","author":"Allen","year":"2018","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.052_bb0260","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12864-016-2888-7","article-title":"Comparison of pre-processing methods for multiplex bead-based immunoassays","volume":"17","author":"Rausch","year":"2016","journal-title":"BMC Genomics"},{"issue":"11","key":"10.1016\/j.ebiom.2018.12.052_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187580","article-title":"Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease","volume":"12","author":"Martyanov","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ebiom.2018.12.052_bb0270","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.rmed.2015.04.008","article-title":"Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis","volume":"109","author":"Nathan","year":"2015","journal-title":"Respir Med"},{"issue":"145","key":"10.1016\/j.ebiom.2018.12.052_bb0275","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0051-2017","article-title":"Evaluating disease severity in idiopathic pulmonary fibrosis","volume":"26","author":"Robbie","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.052_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1513\/AnnalsATS.201703-244FR","article-title":"The value and application of the 6-minute-walk test in idiopathic pulmonary fibrosis","volume":"15","author":"Brown","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.052_bb0285","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm.4010","article-title":"Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice","volume":"22","author":"Chang","year":"2016","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2018.12.052_bb0290","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors","volume":"15","author":"Zhu","year":"2016","journal-title":"Aging Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.ebiom.2018.12.052_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428194.2010.500045","article-title":"Novel disease targets and management approaches for diffuse large B-cell lymphoma","volume":"51","author":"Wilson","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"123","key":"10.1016\/j.ebiom.2018.12.052_bb0300","doi-asserted-by":"crossref","DOI":"10.3791\/55533","article-title":"Techniques to induce and quantify cellular senescence","author":"Noren Hooten","year":"2017","journal-title":"J Vis Exp"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418306297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418306297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T15:57:57Z","timestamp":1662739077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418306297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":60,"alternative-id":["S2352396418306297"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.052","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734825206.793563347","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}